Abstract No. 29 Varian Velocity 4.0’s RapidSphere dosimetry assessment in predicting treatment outcomes following Yttrium-90 transarterial radioembolization (TARE) of hepatic tumors
Year: 2022
Type: conference-abstract
Authors: C. Ward, W. Wesson, J. Mazurek, I. Kozlowski, G. Werner, A. Dehbozorgi, M. Phadnis, C. Walter, A. Rohr, Z. Collins
Institution: University of Kansas Medical Center
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281719207
